Customer Letters

Please note: The following Customer Letters, do not replace the version that you receive from your local Canadian Blood Services site.

* The contents of the customer letters available on this site are current as of their dates of publication. If required, contact your local Hospital Liaison Specialist to determine if the letter is still current.

Displaying 1 - 6 of 6

	Date Sort ascending
CL_2024-06.pdf	2024-01-30	INFORMATION ONLY Updated NAC Recommendations for Use of Irradiated Blood Components in Canada Customer Letter 2024-06 (PDF)
CL_2024-05.pdf	2024-01-29	ACTION REQUIRED New Visual Inspection Tool (VIT) Customer Letter 2024-05 (PDF)
CL_2024-04.pdf	2024-01-22	INFORMATION ONLY Glassia Launch Update Customer Letter 2024-04 (PDF) \| Introducing GLASSIA^® in Canada (PDF)
CL_2024-03.pdf	2024-01-22	INFORMATION ONLY Introducing Rebinyn 3000IU and Esperoct 3000IU Customer Letter 2024-03 (PDF)
CL_2024-02.pdf	2024-01-22	INFORMATION ONLY Illegible Lots on CSL’s Alburex 25% 100mL Customer Letter 2024-02 (PDF) \| Variable Printed Information on Alburex-25 Cartons (PDF)
CL_2024-01.pdf	2024-01-15	INFORMATION ONLY Discontinuation of Directed Donations Customer Letter 2024-01 (PDF)